Danaher Co. (NYSE:DHR) Shares Sold by Raymond James Trust N.A.

Raymond James Trust N.A. cut its stake in Danaher Co. (NYSE:DHRGet Rating) by 3.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,895 shares of the conglomerate’s stock after selling 559 shares during the quarter. Raymond James Trust N.A.’s holdings in Danaher were worth $4,536,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of DHR. US Asset Management LLC increased its stake in Danaher by 0.6% in the 1st quarter. US Asset Management LLC now owns 5,774 shares of the conglomerate’s stock valued at $1,694,000 after buying an additional 37 shares during the last quarter. Mairs & Power Inc. increased its position in Danaher by 4.1% during the 4th quarter. Mairs & Power Inc. now owns 959 shares of the conglomerate’s stock worth $316,000 after purchasing an additional 38 shares in the last quarter. Mutual Advisors LLC increased its position in Danaher by 0.7% in the 4th quarter. Mutual Advisors LLC now owns 5,792 shares of the conglomerate’s stock valued at $1,906,000 after acquiring an additional 40 shares during the period. Encompass Wealth Advisors LLC increased its position in Danaher by 1.9% in the 1st quarter. Encompass Wealth Advisors LLC now owns 2,292 shares of the conglomerate’s stock valued at $672,000 after acquiring an additional 42 shares during the period. Finally, Howe & Rusling Inc. increased its position in shares of Danaher by 48.8% during the first quarter. Howe & Rusling Inc. now owns 128 shares of the conglomerate’s stock worth $38,000 after buying an additional 42 shares during the period. 77.27% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on DHR shares. Sanford C. Bernstein began coverage on shares of Danaher in a research note on Tuesday, August 16th. They issued an “outperform” rating and a $340.00 price objective on the stock. UBS Group raised their price objective on shares of Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. KeyCorp cut their target price on shares of Danaher from $345.00 to $325.00 and set an “overweight” rating for the company in a research report on Friday, July 22nd. Evercore ISI lowered their price objective on shares of Danaher from $320.00 to $280.00 and set an “outperform” rating for the company in a research note on Tuesday, July 5th. Finally, Robert W. Baird increased their price target on shares of Danaher from $319.00 to $325.00 in a research note on Friday, July 22nd. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $321.75.

Danaher Trading Down 0.8 %

Shares of DHR opened at $266.43 on Friday. Danaher Co. has a 1-year low of $233.71 and a 1-year high of $331.68. The company has a 50-day moving average of $280.99 and a 200 day moving average of $269.91. The firm has a market capitalization of $193.81 billion, a price-to-earnings ratio of 31.38, a PEG ratio of 1.29 and a beta of 0.88. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.75 and a quick ratio of 1.32.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 earnings per share for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The company had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. During the same quarter last year, the business posted $2.46 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, research analysts expect that Danaher Co. will post 10.4 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Thursday, September 29th. This represents a $1.00 annualized dividend and a dividend yield of 0.38%. Danaher’s dividend payout ratio is currently 11.78%.

Insider Activity

In other news, Director Walter G. Lohr sold 3,906 shares of the business’s stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the completion of the sale, the director now owns 12,115 shares in the company, valued at approximately $3,317,571.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Danaher news, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the sale, the executive vice president now owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 3,906 shares of the business’s stock in a transaction that occurred on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at approximately $3,317,571.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,906 shares of company stock worth $11,823,179. 11.20% of the stock is currently owned by corporate insiders.

About Danaher

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.